Sökning: id:"swepub:oai:DiVA.org:oru-80694" >
Mortality and Funct...
Mortality and Functionality after Stroke in Patients with Systemic Lupus Erythematosus
-
- Rossides, Marios (författare)
- Karolinska Institutet
-
- Simard, Julia F. (författare)
- Department of Clinical Science and Education, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden; Division of Epidemiology, Department of Health Research and Policy, Stanford University, CA, USA; Division of Immunology and Rheumatology, Department of Medicine, Stanford School of Medicine, Stanford University, Stanford, California, USA
-
- Svenungsson, Elisabet (författare)
- Karolinska Institutet
-
visa fler...
-
- von Euler, Mia, 1967- (författare)
- Karolinska Institutet
-
- Arkema, Elizabeth V. (författare)
- Karolinska Institutet
-
visa färre...
-
(creator_code:org_t)
- 2017-09-15
- 2017
- Engelska.
-
Ingår i: Journal of Rheumatology. - Toronto, Canada : The Journal of Rheumatology Publishing Co. Ltd. - 0315-162X .- 1499-2752. ; 44:11, s. 1590-1596
- Relaterad länk:
-
https://urn.kb.se/re...
-
visa fler...
-
https://doi.org/10.3...
-
http://kipublication...
-
visa färre...
Abstract
Ämnesord
Stäng
- OBJECTIVE: To investigate mortality and functional impairment after stroke in systemic lupus erythematosus (SLE).METHODS: Using Swedish nationwide registers, we identified 423 individuals with SLE and 1652 people without SLE who developed a first-ever ischemic or hemorrhagic stroke (1998-2013) and followed them until all-cause death or for 1 year. HR for death after ischemic or hemorrhagic stroke and the risk ratio of functional impairment (dependence in either transferring, toileting, or dressing) 3 months after ischemic stroke were estimated.RESULTS: One year after stroke, 22% of patients with SLE versus 16% of those without SLE died. After ischemic stroke, patients with SLE had an increased risk of death (HR 1.85, 95% CI 1.39-2.45), which was attenuated after controlling for SLE-related comorbidities (HR 1.41, 95% CI 1.04-1.91). Functional impairment at 3 months was increased in SLE by almost 2-fold (risk ratio 1.73, 95% CI 1.16-2.57). After hemorrhagic stroke, patients with SLE had an HR of 2.30 (95% CI 1.38-3.82) for death, which was increased even during the first month.CONCLUSION: Compared to subjects without SLE, mortality after ischemic stroke increases after the first month in individuals with SLE, and functionality is worse at 3 months. SLE is associated with all-cause death after hemorrhagic stroke even during the first month. A shift of focus to patient functionality and prevention of hemorrhagic strokes is required.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Reumatologi och inflammation (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Rheumatology and Autoimmunity (hsv//eng)
Nyckelord
- Activities of daily living
- Cerebrovascular disorders
- Stroke rehabilitation
- Survival analysis
- Systemic lupus erythematosus
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas